Cheminformatics platform for drug discovery and chemical data management
Chemaxon operates a cheminformatics platform serving over 1 million scientists and researchers globally. The tech stack reveals a cloud-native, containerized architecture (AWS EKS, Kubernetes, Docker, Terraform) paired with a polyglot backend (Python, Go, Java, C#) and modern frontends (React, Angular) — a shape consistent with migrating legacy monoliths toward microservices. Active hiring is concentrated in engineering (senior-heavy mix) and support, with all roles in Hungary, suggesting they're scaling internal capacity around the Certara acquisition rather than geographic expansion.
Chemaxon is a cheminformatics company that provides tools for chemical visualization, database management, structure handling, and drug discovery workflows. The platform is used by researchers, academics, and scientists to manage chemical data and accelerate scientific work. In 2024, Chemaxon joined Certara, a drug development and biosimulation company, to integrate cheminformatics into the broader design-make-test-analyze cycle. The company operates with 201–500 employees based in Budapest and serves enterprise and academic customers with data-heavy B2B tools.
Chemaxon runs on AWS (EKS, ECS, Lambda, CloudFront, API Gateway), containerized with Docker and Kubernetes, orchestrated via Terraform and Helm. Backend: Python, Go, Java, C#, Bash. Frontend: React, Angular. Data: PostgreSQL. CI/CD: GitLab, Argo CD.
Current projects include modernizing the data management platform architecture, launching a design system, improving UX for data-heavy tools, developing biological registration capabilities, and advancing large-molecule algorithms for the Certara IQ platform.
Other companies in the same industry, closest in size